Evicenter
MarkdownMedical informationP&T meetings
Ifezuntirgene inilparvovec (AMT-130)

Huntington's disease

Manufacturer
uniQure
Launch
Not announced
Last updated
291 sources

Product information and disease descriptionPlace of product in therapyApproaches to treatment

Care management intervention strategies

12 evidence topics · 14 sources

Summary
  • Procedure and monitoring analogs: the prescribing information for Kebilidi, a product administered by stereotactic neurosurgery, directs monitoring for procedure-related adverse events, including continuous cardiorespiratory monitoring during hospitalization, and the FDA review states that procedural complications can be mitigated by post-procedural monitoring. Aetna considers brain MRI for stereotactic planning and intraoperative navigation medically necessary for members being considered for Kebilidi.
  • Long-term follow-up: FDA guidance recommends long-term follow-up of up to five years for AAV vectors, with a risk-based approach to duration for vectors capable of long term expression without integration, such as AAV.
  • Multidisciplinary care: a multidisciplinary position paper recommends a multidisciplinary team, an individualised care and treatment plan for every patient and family, and a case manager or coordinator. The Huntington's Disease Society of America states that no one doctor or caregiver should manage all aspects of an HD case, and that the goals of treatment are to reduce the burden of symptoms, maximize function, and optimize quality of life. HDSA Centers of Excellence provide neurologists, psychiatrists, social workers, therapists, counselors, and other professionals.
  • Advance care planning: one guideline describes advance care planning as essential, including discussion of alternative feeding methods, and another recommends documenting living wills and care directives early and social worker support for financial assistance. In one study, engaging in advance care planning did not cause untoward effects on health-related quality of life or suicidal thoughts and behavior (STB), whose lifetime prevalence in HD approaches 30%.
  • Palliative care: a review included 38 of 333 articles and found a low level of evidence for most topics. One publication states that referral to palliative care should be strongly considered for patients with pain, anxiety, sleep disturbances, and difficulty coping with the diagnosis.